Literature DB >> 16357620

A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings.

Blai Dalmau Obrador1, Montserrat Gil Prades, Mercedes Vergara Gómez, Jordi Puig Domingo, Rosa Bella Cueto, Montserrat Rué, Jordi Real, Pere Mas Guiteras.   

Abstract

OBJECTIVE: To develop and validate a non-invasive index to predict the presence of cirrhosis in patients with chronic hepatitis C on the basis of clinical, laboratory, and ultrasound findings.
MATERIALS AND METHODS: Data from the complete history and physical examination, serologic studies, liver ultrasound, and liver biopsy of patients with chronic hepatitis C were analyzed using multivariate regression to develop a cirrhosis predictive index. This index was then applied prospectively to another group of patients with chronic hepatitis C to determine its accuracy.
RESULTS: Three hundred and thirty-two patients were included (mean age, 48.5+/-18.7 years; male-female ratio, 1.27). Sixty-seven patients (20%) had cirrhosis at histology. Logistic regression identified seven variables that predicted cirrhosis: age>or=60 years, platelet count<or=100 (x10/L), AST/ALT>or=1, prothrombin time (Ratio)>or=1.1, caudate hypertrophy, right lobe atrophy and splenomegaly. Patients scoring>or=22 in total had a statistically significant probability of cirrhosis (sensitivity, 80%; specificity, 96%; and diagnostic accuracy, 94%).
CONCLUSION: Cirrhosis can be predicted in patients with chronic hepatitis C by the evaluation of seven clinical, laboratory, and sonographic variables. The index will be useful for the management and follow-up of hepatitis C patients drastically reducing the indications for biopsy in this context.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357620     DOI: 10.1097/00042737-200601000-00010

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Non invasive tools for the diagnosis of liver cirrhosis.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Melchiorre Cervello; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma?

Authors:  Antonio Pesce; Roberto Scilletta; Angela Branca; Luciano Nigro; Arturo Montineri; Licia Larocca; Filippo Fatuzzo; Marine Castaing; Stefano Puleo
Journal:  HPB (Oxford)       Date:  2012-03-28       Impact factor: 3.647

3.  Quantifying liver cirrhosis by extracting significant features from MRI T2 image.

Authors:  Ming-Hong Hshiao; Po-Chou Chen; Jo-Chi Jao; Yung-Hui Huang; Chen-Chang Lee; Shih-Yu Chao; Li-Wei Lin; Tai-Been Chen
Journal:  ScientificWorldJournal       Date:  2012-06-18

4.  Phenotype-genotype correlation in Wilson disease in a large Lebanese family: association of c.2299insC with hepatic and of p. Ala1003Thr with neurologic phenotype.

Authors:  Julnar Usta; Antonios Wehbeh; Khaled Rida; Omar El-Rifai; Theresa Alicia Estiphan; Tamar Majarian; Kassem Barada
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

5.  Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.

Authors:  Inhwan Jeon; Eun-Suk Cho; Joo Hee Kim; Dae Jung Kim; Jeong-Sik Yu; Jae-Joon Chung
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.